重写RNA代码:一个以m6a为中心的框架来分类瘤和指导组合疗法
Yi Sun1, Jinliang Wu2, Guanhao Chen2
1Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Frontiers in immunology
|February 16, 2026
概括
这项研究引入了一个新的框架来根据N6 - 甲基氨酸 (m6A) 失调对瘤进行分类. 这种方法旨在克服个性化癌症治疗的上下文依赖性,并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 表皮转录组,特别是N6 - - 甲基氨酸 (m6A) 修饰,在癌症的发展和进展中起着至关重要的作用.
- 在不同瘤类型中,m6A调节者的上下文依赖性影响阻碍了m6A知识的临床应用.
研究的目的:
- 开发一种临床上可行的分类学框架,以主导失调的m6A成分为基础对瘤进行分类.
- 为了克服背景依赖在癌症中A的作用的挑战.
主要方法:
- 从PubMed和谷歌学者的初级研究和高影响力的论文进行系统审查.
- 整合泛癌分子数据,包括调节器表达,遗传依赖和m6A景观.
- 定义和表征 m6A驱动的分子亚型.
主要成果:
- 一个新的分类学框架,将瘤分为写作主导,删除高,读者放大和免疫调节子类型.
- 每个亚型都表现出不同的致癌方案,治疗抵抗机制和可操作的治疗漏洞.
- 开发一个诊断-治疗路线图,整合液体活检为m6A生物标志物检测和亚型特定的治疗分配.
结论:
- 准m6A表体转录组为瘤学提供了一个范式转变.
- 拟议的框架提供了一种战略方法来克服上下文依赖性,使瘤分类,脆弱性预测和个性化治疗成为可能.
- 通过生物标志物引导的组合疗法,将表体转录学见解转化为患者的益处,这一框架有助于实现这一目标.
关键词:
N6 - 甲基腺素 (m6A) 的使用.基因组RNA的修饰是RNA的修饰.癌症免疫疗法免疫疗法副本转录组 (epitranscriptome) 是一个副本转录组.有针对性的治疗.治疗性抗药性是一种治疗性抗药性.更多相关视频
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
9.5K
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
25.1K
相关概念视频
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K